259 related articles for article (PubMed ID: 33845831)
1. A cell-to-patient machine learning transfer approach uncovers novel basal-like breast cancer prognostic markers amongst alternative splice variants.
Villemin JP; Lorenzi C; Cabrillac MS; Oldfield A; Ritchie W; Luco RF
BMC Biol; 2021 Apr; 19(1):70. PubMed ID: 33845831
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells.
Naro C; De Musso M; Delle Monache F; Panzeri V; de la Grange P; Sette C
J Exp Clin Cancer Res; 2021 Dec; 40(1):397. PubMed ID: 34930366
[TBL] [Abstract][Full Text] [Related]
3. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
[TBL] [Abstract][Full Text] [Related]
4. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence.
Ortiz-Martínez F; Perez-Balaguer A; Ciprián D; Andrés L; Ponce J; Adrover E; Sánchez-Payá J; Aranda FI; Lerma E; Peiró G
Hum Pathol; 2014 Mar; 45(3):504-12. PubMed ID: 24440093
[TBL] [Abstract][Full Text] [Related]
5. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.
D'Amato NC; Ostrander JH; Bowie ML; Sistrunk C; Borowsky A; Cardiff RD; Bell K; Young LJ; Simin K; Bachelder RE; Delrow J; Dawson A; Yee LD; Mrózek K; Clay TM; Osada T; Seewaldt VL
PLoS One; 2012; 7(9):e45684. PubMed ID: 23049838
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
Roll JD; Rivenbark AG; Sandhu R; Parker JS; Jones WD; Carey LA; Livasy CA; Coleman WB
Exp Mol Pathol; 2013 Dec; 95(3):276-87. PubMed ID: 24045095
[TBL] [Abstract][Full Text] [Related]
7. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.
Shapiro IM; Cheng AW; Flytzanis NC; Balsamo M; Condeelis JS; Oktay MH; Burge CB; Gertler FB
PLoS Genet; 2011 Aug; 7(8):e1002218. PubMed ID: 21876675
[TBL] [Abstract][Full Text] [Related]
8. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
Blick T; Hugo H; Widodo E; Waltham M; Pinto C; Mani SA; Weinberg RA; Neve RM; Lenburg ME; Thompson EW
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):235-52. PubMed ID: 20521089
[TBL] [Abstract][Full Text] [Related]
9. Expression of markers of stem cell characteristics, epithelial-mesenchymal transition, basal-like phenotype, proliferation, and androgen receptor in metaplastic breast cancer and their prognostic impact.
Voutilainen S; Heikkilä P; Sampo M; Nevanlinna H; Blomqvist C; Mattson J
Acta Oncol; 2021 Sep; 60(9):1233-1239. PubMed ID: 34282709
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
11. Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach.
Mercatelli D; Formaggio F; Caprini M; Holding A; Giorgi FM
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750607
[TBL] [Abstract][Full Text] [Related]
12. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors.
Sizemore ST; Sizemore GM; Booth CN; Thompson CL; Silverman P; Bebek G; Abdul-Karim FW; Avril S; Keri RA
Breast Cancer Res Treat; 2014 Jul; 146(1):25-40. PubMed ID: 24847890
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).
Oliveras-Ferraros C; Corominas-Faja B; Cufí S; Vazquez-Martin A; Martin-Castillo B; Iglesias JM; López-Bonet E; Martin ÁG; Menendez JA
Cell Cycle; 2012 Nov; 11(21):4020-32. PubMed ID: 22992620
[TBL] [Abstract][Full Text] [Related]
15. Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes.
Cava C; Armaos A; Lang B; Tartaglia GG; Castiglioni I
Sci Rep; 2022 Jan; 12(1):693. PubMed ID: 35027621
[TBL] [Abstract][Full Text] [Related]
16. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
[TBL] [Abstract][Full Text] [Related]
17. Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature.
Emad A; Ray T; Jensen TW; Parat M; Natrajan R; Sinha S; Ray PS
Breast Cancer Res; 2020 Jul; 22(1):74. PubMed ID: 32641077
[TBL] [Abstract][Full Text] [Related]
18. A novel gene expression signature for bone metastasis in breast carcinomas.
Savci-Heijink CD; Halfwerk H; Koster J; van de Vijver MJ
Breast Cancer Res Treat; 2016 Apr; 156(2):249-59. PubMed ID: 26965286
[TBL] [Abstract][Full Text] [Related]
19. DACH1: its role as a classifier of long term good prognosis in luminal breast cancer.
Powe DG; Dhondalay GK; Lemetre C; Allen T; Habashy HO; Ellis IO; Rees R; Ball GR
PLoS One; 2014; 9(1):e84428. PubMed ID: 24392136
[TBL] [Abstract][Full Text] [Related]
20. Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning.
Youssef G; Gammon L; Ambler L; Lunetto S; Scemama A; Cottom H; Piper K; Mackenzie IC; Philpott MP; Biddle A
Elife; 2023 Nov; 12():. PubMed ID: 37975646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
